EXAMINE: targeting risk and treatment in diabetes

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2015-10, Vol.386 (10002), p.1443-1444
Main Authors: Riche, Daniel M, Davis, Courtney
Format: Article
Language:English
Subjects:
Acute Coronary Syndrome - prevention & control
Diabetes Mellitus, Type 2 - prevention & control
Diabetic Cardiomyopathies - prevention & control
Female
Heart Failure - chemically induced
Humans
Hypoglycemic Agents - adverse effects
Internal Medicine
Male
Piperidines - adverse effects
Uracil - analogs & derivatives
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3
cites cdi_FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3
container_end_page 1444
container_issue 10002
container_start_page 1443
container_title The Lancet (British edition)
container_volume 386
creator Riche, Daniel M
Davis, Courtney
description
doi_str_mv 10.1016/S0140-6736(15)00406-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1722927441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673615004067</els_id><sourcerecordid>1722927441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3</originalsourceid><addsrcrecordid>eNqFkLtOwzAUQC0EouXxCaCMZQjY8athAFVVgUo8Bjp0sxz7BrlNk2K7SP170hY6sDB5Offc64PQBcHXBBNx844Jw6mQVPQIv8KYYZHKA9QlTLKUMzk9RN090kEnIcxwSwnMj1EnE0wIzEgXkdF08DJ-Hd0mUfsPiK7-SLwL80TXNokedFxAHRNXJ9bpAiKEM3RU6irA-c97iiYPo8nwKX1-exwPB8-pYULGtE9LgS3jmFNGNc8I51SaQmtjc1v0cyoEzYzVtCRlDu3VlhqZCS3zwnCw9BT1dtqlbz5XEKJauGCgqnQNzSooIrMszyRjpEX5DjW-CcFDqZbeLbRfK4LVJpbaxlKbEopwtY2lZDt3-bNiVSzA7qd-67TA_Q6A9p9fDrwKxkFtwDoPJirbuH9X3P0xmMrVzuhqDmsIs2bl6zaiIipkCu8kGwfhW4Ok36DJi8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1722927441</pqid></control><display><type>article</type><title>EXAMINE: targeting risk and treatment in diabetes</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Riche, Daniel M ; Davis, Courtney</creator><creatorcontrib>Riche, Daniel M ; Davis, Courtney</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(15)00406-7</identifier><identifier>PMID: 26466041</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Coronary Syndrome - prevention &amp; control ; Diabetes Mellitus, Type 2 - prevention &amp; control ; Diabetic Cardiomyopathies - prevention &amp; control ; Female ; Heart Failure - chemically induced ; Humans ; Hypoglycemic Agents - adverse effects ; Internal Medicine ; Male ; Piperidines - adverse effects ; Uracil - analogs &amp; derivatives</subject><ispartof>The Lancet (British edition), 2015-10, Vol.386 (10002), p.1443-1444</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3</citedby><cites>FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26466041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riche, Daniel M</creatorcontrib><creatorcontrib>Davis, Courtney</creatorcontrib><title>EXAMINE: targeting risk and treatment in diabetes</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><subject>Acute Coronary Syndrome - prevention &amp; control</subject><subject>Diabetes Mellitus, Type 2 - prevention &amp; control</subject><subject>Diabetic Cardiomyopathies - prevention &amp; control</subject><subject>Female</subject><subject>Heart Failure - chemically induced</subject><subject>Humans</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Piperidines - adverse effects</subject><subject>Uracil - analogs &amp; derivatives</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkLtOwzAUQC0EouXxCaCMZQjY8athAFVVgUo8Bjp0sxz7BrlNk2K7SP170hY6sDB5Offc64PQBcHXBBNx844Jw6mQVPQIv8KYYZHKA9QlTLKUMzk9RN090kEnIcxwSwnMj1EnE0wIzEgXkdF08DJ-Hd0mUfsPiK7-SLwL80TXNokedFxAHRNXJ9bpAiKEM3RU6irA-c97iiYPo8nwKX1-exwPB8-pYULGtE9LgS3jmFNGNc8I51SaQmtjc1v0cyoEzYzVtCRlDu3VlhqZCS3zwnCw9BT1dtqlbz5XEKJauGCgqnQNzSooIrMszyRjpEX5DjW-CcFDqZbeLbRfK4LVJpbaxlKbEopwtY2lZDt3-bNiVSzA7qd-67TA_Q6A9p9fDrwKxkFtwDoPJirbuH9X3P0xmMrVzuhqDmsIs2bl6zaiIipkCu8kGwfhW4Ok36DJi8A</recordid><startdate>20151010</startdate><enddate>20151010</enddate><creator>Riche, Daniel M</creator><creator>Davis, Courtney</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151010</creationdate><title>EXAMINE: targeting risk and treatment in diabetes</title><author>Riche, Daniel M ; Davis, Courtney</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Coronary Syndrome - prevention &amp; control</topic><topic>Diabetes Mellitus, Type 2 - prevention &amp; control</topic><topic>Diabetic Cardiomyopathies - prevention &amp; control</topic><topic>Female</topic><topic>Heart Failure - chemically induced</topic><topic>Humans</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Piperidines - adverse effects</topic><topic>Uracil - analogs &amp; derivatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riche, Daniel M</creatorcontrib><creatorcontrib>Davis, Courtney</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riche, Daniel M</au><au>Davis, Courtney</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EXAMINE: targeting risk and treatment in diabetes</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2015-10-10</date><risdate>2015</risdate><volume>386</volume><issue>10002</issue><spage>1443</spage><epage>1444</epage><pages>1443-1444</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26466041</pmid><doi>10.1016/S0140-6736(15)00406-7</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2015-10, Vol.386 (10002), p.1443-1444
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_1722927441
source ScienceDirect Freedom Collection 2022-2024
subjects Acute Coronary Syndrome - prevention & control
Diabetes Mellitus, Type 2 - prevention & control
Diabetic Cardiomyopathies - prevention & control
Female
Heart Failure - chemically induced
Humans
Hypoglycemic Agents - adverse effects
Internal Medicine
Male
Piperidines - adverse effects
Uracil - analogs & derivatives
title EXAMINE: targeting risk and treatment in diabetes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A09%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EXAMINE:%20targeting%20risk%20and%20treatment%20in%20diabetes&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Riche,%20Daniel%20M&rft.date=2015-10-10&rft.volume=386&rft.issue=10002&rft.spage=1443&rft.epage=1444&rft.pages=1443-1444&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(15)00406-7&rft_dat=%3Cproquest_cross%3E1722927441%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c467t-83f60d4505343a5215537cbaacd9db8936632cda3f1f9e147d3c726a79bc5ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1722927441&rft_id=info:pmid/26466041&rfr_iscdi=true